CDCA7L and cervical carcinoma: Positive binding by hR1 and Hex-hR1 was demonstrated in MCF7 (breast cancer), DU 145 (prostate cancer), ME-180 (cervical cancer) and RH-30 (rhabdomyosarcoma) by flow cytometry (Table 4).